Sara Kenkare-Mitra
CIK: 0001895592
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- May 14, 2026UNCY
Unicycive Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
47.9K shares- - May 14, 2026UNCY
Unicycive Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
42.1K shares- - May 14, 2026UNCY
Unicycive Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
84.2K shares- - May 14, 2026UNCY
Unicycive Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
84.2K shares- - May 14, 2026UNCY
Unicycive Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
42.1K shares- - Dec 3, 2025ALEC
Alector, Inc.
Sale(S)Direct41.7K shares at avg. $1.12$47K - Sep 2, 2025ALEC
Alector, Inc.
Sale(S)Direct23.6K shares at avg. $2.50$59K - Jul 28, 2025UNCY
Unicycive Therapeutics, Inc.
Award(A)DirectStock Options
21.2K shares- - Jul 1, 2025ALEC
Alector, Inc.
Award(A)Direct54.7K shares- - Jun 2, 2025ALEC
Alector, Inc.
Sale(S)Direct23.9K shares at avg. $1.34$32K - Mar 3, 2025ALEC
Alector, Inc.
Sale(S)Direct29.1K shares at avg. $1.47$43K - Dec 2, 2024ALEC
Alector, Inc.
Sale(S)Direct26.5K shares at avg. $2.52$67K - Oct 1, 2024ALEC
Alector, Inc.
Award(A)Direct300K shares- - Sep 3, 2024ALEC
Alector, Inc.
Sale(S)Direct13.9K shares at avg. $4.88$68K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 |  UNCY Unicycive Therapeutics, Inc. | Award(A) Restricted Stock Units | 47,941 | - | - | Direct |
| May 14, 2026 | UNCY Unicycive Therapeutics, Inc. | Award(A) Restricted Stock Units | 42,100 | - | - | Direct |
| May 14, 2026 | UNCY Unicycive Therapeutics, Inc. | Award(A) Restricted Stock Units | 84,200 | - | - | Direct |
| May 14, 2026 | UNCY Unicycive Therapeutics, Inc. | Award(A) Restricted Stock Units | 84,200 | - | - | Direct |
| May 14, 2026 | UNCY Unicycive Therapeutics, Inc. | Award(A) Restricted Stock Units | 42,100 | - | - | Direct |
| Dec 3, 2025 |  ALEC Alector, Inc. | Sale(S) | 41,687 | $1.12 | $46,673 | Direct |
| Sep 2, 2025 | ALEC Alector, Inc. | Sale(S) | 23,638 | $2.50 | $59,019 | Direct |
| Jul 28, 2025 | UNCY Unicycive Therapeutics, Inc. | Award(A) Stock Options | 21,200 | - | - | Direct |
| Jul 1, 2025 | ALEC Alector, Inc. | Award(A) | 54,725 | - | - | Direct |
| Jun 2, 2025 | ALEC Alector, Inc. | Sale(S) | 23,890 | $1.34 | $31,974 | Direct |
| Mar 3, 2025 | ALEC Alector, Inc. | Sale(S) | 29,073 | $1.47 | $42,662 | Direct |
| Dec 2, 2024 | ALEC Alector, Inc. | Sale(S) | 26,500 | $2.52 | $66,764 | Direct |
| Oct 1, 2024 | ALEC Alector, Inc. | Award(A) | 300,000 | - | $0 | Direct |
| Sep 3, 2024 | ALEC Alector, Inc. | Sale(S) | 13,926 | $4.88 | $67,981 | Direct |
1-14 of 14 transactions
About Kenkare-Mitra Sara
Kenkare-Mitra Sara (SEC CIK 0001895592) files insider reports with the SEC as Director of Unicycive Therapeutics, Inc. (UNCY) and President and Head of R&D of Alector, Inc. (ALEC).
Signal8 holds 12 ownership filings by Kenkare-Mitra Sara, all Form 4s, filed between Sep 4, 2024 and Jul 28, 2026. Those filings report 14 transactions, from Sep 3, 2024 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kenkare-Mitra Sara's filings is in MOUNTAIN VIEW, CA.
Recent filings by Kenkare-Mitra Sara
- May 14, 2026: Grants or awards of UNCY derivative securities (5 lines, Form 4, code A).
- Dec 3, 2025: Open-market sale of ALEC shares (Form 4, code S).
- Sep 2, 2025: Open-market sale of ALEC shares (Form 4, code S).
- Jul 28, 2025: Grant or award of UNCY derivative securities (Form 4, code A).
- Jul 1, 2025: Grant or award of ALEC shares (Form 4, code A).
Other insiders filing for Unicycive Therapeutics, Inc. (UNCY)
- Manning Meredith, Director
- Laumas Sandeep, Director
- Gupta Shalabh K., CEO
- Gupta Pramod, EVP, Pharmaceuticals and BD
- Townsend John, CFO
- Jermasek Douglas, EVP, Corporate Strategy